Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Chris W. who wrote (2333)	6/22/1999 8:31:00 PM
From: John Metcalf	Read Replies (2) \| Respond to of 2742

CIST was up 23% on the bid today. Of course, if you bought it yesterday at 31 cents asked, and sold it today at 32 cents bid, you are not thrilled. NEVERTHELESS, they accomplished something. 1) They have Dr. Grausz (founder, who owes them money) substantially out of the stock, and have disposed 25% potentially hostile voting power. 2) They made a _good investment_, paying $.2274 for stock that is selling for $.32. 3) They increased the cash value per share by 8 cents (nearly 25% over yesterday's closing bid). Adjusting the balance sheet (from the 10-K of Dec 31 98) for today's action, I calculate a cash value per share of 58 cents. In addition, I expect the company to sell at a premium to cash due to the Pasteur-Merrieux-Connaught deal, TECH royalty stream, and other patent rights. Accordingly, I now believe the company will be sold in the 75 cent to a dollar range. This would make me a happy, but homesick, camper.